Exploring the role of adipsin in statin-induced glucose intolerance: a prospective open label study.
Background Evidence from the literature, highlights the increased risk of developing glucose intolerance and type 2 diabetes mellitus (T2DM) with statin therapy. In addition, few animal studies demonstrate that adipsin secreted from adipocytes plays a cru.....